enGene Therapeutics (ENGN) Share-based Compensation (2023 - 2026)
enGene Therapeutics (ENGN) recorded Share-based Compensation of $7.81 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), up 202.6% from $2.58 million a year earlier and up 88.4% from the prior quarter.
enGene Therapeutics (ENGN) Share-based Compensation (2023 - 2026) Analysis & Trends
On a TTM basis, enGene Therapeutics' Share-based Compensation came in at $17.36 million as of Jul 31, 2026, up 99.7% year-over-year; for FY2025 (ended Oct 31, 2025), it was $9.65 million, up 81.2% from FY2024.
- Annual Share-based Compensation has a three-year compound annual growth rate of 336.5% (FY2022 to FY2025).
- Across earlier fiscal years, Share-based Compensation came in at $5.32 million in FY2024 (+54.3%), $3.45 million in FY2023 and $116,000 in FY2022.
- The fiscal Q3 2026 figure is the highest quarterly Share-based Compensation in data going back to fiscal Q1 2023.
- On a year-over-year basis, Share-based Compensation has increased for seven consecutive quarters, with growth averaging 119.7% over the last eight quarters.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 521.6% in fiscal Q1 2025, against a decline of 50.6% in fiscal Q4 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $4.15 million (Q2 2026), $2.8 million (Q1 2026) and $2.61 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 249.00 Mn |
| 10 | enGene Therapeutics | 105.88 Mn | -888.59 Mn | - | 7.81 Mn |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 7.81 Mn |
| Apr 30, 2026 | 4.15 Mn |
| Jan 31, 2026 | 2.80 Mn |
| Oct 31, 2025 | 2.61 Mn |
| Jul 31, 2025 | 2.58 Mn |
| Apr 30, 2025 | 2.65 Mn |
| Jan 31, 2025 | 1.81 Mn |
| Oct 31, 2024 | 1.66 Mn |
| Jul 31, 2024 | 1.46 Mn |
| Apr 30, 2024 | 1.92 Mn |
| Jan 31, 2024 | 291,000.00 |
| Oct 31, 2023 | 3.35 Mn |
| Jul 31, 2023 | 37,000.00 |
| Apr 30, 2023 | 39,000.00 |
| Jan 31, 2023 | 20,000.00 |
enGene Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();